VICKIE CHENG: Open Payments
NPI 1548715170 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,626 in 117 payments from 21 companies in 2025. Trend: 2023 $1,280 · 2024 $1,405 · 2025 $2,626
Food & beverage: $2,426Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $553 |
| GENZYME CORPORATION | 8 | $402 |
| Galderma Laboratories, L.P. | 13 | $358 |
| UCB, Inc. | 12 | $274 |
| MAYNE PHARMA COMMERCIAL LLC | 19 | $171 |
| Novartis Pharmaceuticals Corporation | 5 | $132 |
| PFIZER INC. | 6 | $116 |
| Arcutis Biotherapeutics, Inc. | 4 | $97 |
| ABBVIE INC. | 4 | $92 |
| Lilly USA, LLC | 3 | $77 |
Products named: TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, Zoryve, AKLIEF, COSENTYX, TALTZ.
Industry payments across CA — which companies pay providers there.
